The following is supplemental information, including discontinued operations, relating to the Condensed Consolidated Statements of Cash Flows (in thousands):


	Six Months Ended
	July 3, 2026		June 27, 2025
Noncash investing and financing activities:
Property, plant and equipment purchases included in accounts payable	$	9,520	$	19,568
Accrued excise tax associated with share repurchases	297		—
Common stock issued for conversion of debt	—		183,972
Common stock received under capped call upon conversion of debt	—		26,858
Write-off of unamortized deferred costs and original issue discount upon conversion of debt included in Additional paid in capital	—		5,124
Common stock issued for acquisition	—		3,989

Debt issuance costs incurred but not yet paid	—		120
Supplemental lease disclosures:
Assets acquired under operating leases	309		11,147
Assets acquired under finance leases	22,917		5,764

The Company has receivable factoring arrangements, pursuant to which certain receivables may be sold on a non-recourse basis to financial institutions. Factoring fees are recorded in Selling, general, and administrative expenses in the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income. During the six months ended July 3, 2026 and June 27, 2025, the Company sold accounts receivable of $25.1 million and $131.1 million, respectively. The Company recorded factoring fees of $0.1 million for the six months ended July 3, 2026, compared to $0.5 million and $0.9 million, respectively, for the three and six months ended June 27, 2025.

The Company utilizes supplier financing arrangements with financial institutions to sell certain accounts receivable on a non-recourse basis. Fees for supplier financing arrangements are recorded in Selling, general, and administrative expenses in the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income. During the six months ended July 3, 2026 and June 27, 2025, the Company sold and de-recognized accounts receivable of $84.8 million and $83.5 million, respectively. The Company recorded costs associated with the supplier financing arrangements of $0.4 million and $0.9 million, respectively, for the three and six months ended July 3, 2026, compared to $0.5 million and $1.0 million, respectively, for the three and six months ended June 27, 2025.